Psychiatr. pro Praxi, 2010; 11(1): 22-24

News in electroconvulsive therapy

doc.MUDr.Ladislav Hosák, Ph.D.
Psychiatrická klinika, UK v Praze, LF v Hradci Králové a FN Hradec Králové
Elektrokonvulzivní terapie (EKT) je v léčbě duševních poruch využívána již sedm desítek let. Ani za tuto dobu však neztratila na své účinnosti

Electroconvulsive therapy (ECT) has already been used in the treatment of mental disorders for seven decades. ECT has not even lost its

efficacy and topicality in this period of time. The newest knowledge on electroconvulsive treatment published in reputable international

professional journals in 2009 is summed up in this review. ECT is suitable to treat pharmacoresistant schizophrenia, where it can even

reinduce previously lost treatment response to psychotropic drugs. ECT is also efficient in comorbid obsessive-compulsive symptoms.

There is no sense to be afraid of applying ECT even in a depression with serious physical comorbidity in a geriatric patient, as shown in

one case report. Serious, psychotic, and pharmacoresistant depressions remain basic indications for ECT. Electroconvulsions may also

be used in neurological indications, e. g. Parkinson´s disease. Possible augmentative strategies as well as procedures to avoid adverse

effects, mostly cardiovascular ones, are recently studied in ECT research.

Keywords: electroconvulsive therapy, depression, schizophrenia, adverse effects

Published: January 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hosák L. News in electroconvulsive therapy. Psychiatr. praxi. 2010;11(1):22-24.
Download citation

References

  1. Sienaert P, Vansteelandt K, Demyttenaere K, Peuskens J. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response. Bipolar Disord 2009; 11(4): 418-424. Go to original source... Go to PubMed...
  2. Ravanič DB, Pantovič MM, Milovanovič DR, et al. Long-term efficacy of electroconvulsive therapy combined with different antipsychotic drugs in previously resistant schizophrenia. Psychiatr Danub 2009; 21(2): 179-186. Go to PubMed...
  3. Hustiq H, Onilov R. ECT rekindles pharmacological response in schizophrenia. Eur Psychiatry 2009 (in print). Go to original source... Go to PubMed...
  4. Hanisch F, Friedemann J, Piro J, Gutmann P. Maintenance Electroconvulsive Therapy for Comorbid Pharmacotherapyrefractory Obsessive-compulsive and Schizoaffective Disorder. Eur J Med Res 2009; 14(8): 367-368. Go to original source... Go to PubMed...
  5. Nilsson BM, Ekselius L. Acute and Maintenance Electroconvulsive Therapy for Treatment of Severely Disabling Obsessive-Compulsive Symptoms in a Patient With Asperger Syndrome. J ECT 2009 (in print). Go to original source... Go to PubMed...
  6. Kucia KA, Stepanczak R, Tredzbor B. Electroconvulsive therapy for major depression in an alderly person with epilepsy. World J Biol Psychiatry 2009; 10(1): 78-80. Go to original source... Go to PubMed...
  7. Takahashi S, Mizukami K, Yasuno F, Asada T. Depression associated with dementia with Lewy bodies (DLB) and the effect of somatotherapy. Psychogeriatrics 2009; 9(2): 56-61. Go to original source... Go to PubMed...
  8. Popeo D, Kellner CH. ECT for Parkinson´s disease. Med Hypotheses 2009 (in print). Go to original source... Go to PubMed...
  9. Loo CK, Kaill A, Paton P, Simpson B. The difficult-to-treat electroconvulsive therapy patient - Strategies for augmenting outcomes. J Affect Disord 2009 (in print). Go to original source... Go to PubMed...
  10. Sackeim HA, Dillingham EM, Prudic J, et al. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Arch Gen Psychiatry 2009; 66(7): 729-737. Go to original source... Go to PubMed...
  11. Kuwahara T, Yoshino A, Horikawa N, Nomura S. Delayed sympathetic hyperactivity following electroconvulsive therapy in patients with catatonic schizophrenia. Nihon Shinkei Seishin Yakurigaku Zasshi 2009; 29(2): 79-83. Go to PubMed...
  12. Chandra PA, Golduber G, Chuprun D, Chandra AB. Takotsubo cardiomyopathy following electroconvulsive therapy. J Cardiovasc Med 2009; 10(4): 333-335. Go to original source... Go to PubMed...
  13. Freeman SA. Post-electroconvulsive therapy agitation with etomidate. J ECT 2009; 25(2): 133-134. Go to original source... Go to PubMed...
  14. Kennedy SH, Milev R, Giacobbe P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord 2009 (in print). Go to original source... Go to PubMed...
  15. Rosenberg O, Shoenfeld N, Kotler M, Dannon PN. Mood disorders in elderly population: neurostimulative treatment possibilities. Recent Pat CNS Drug Discov 2009; 4(2): 149-159. Go to original source... Go to PubMed...
  16. Antunes PB, Fleck MP. Clinical Outcomes and Quality of Life in Patients Submitted to Electroconvulsive Therapy. J ECT 2009 (in print).
  17. McDonald A, Walter G. Hollywood and ECT. Int Rev Psychiatry 2009; 21(3): 200-206. Go to original source... Go to PubMed...
  18. Smith M, Vogler J, Zarrouf F, et al. Electroconvulsive therapy: the struggles in the decision-making process and the aftermath of treatment. Issues Ment Health Nurs 2009; 30(9): 554-559. Go to original source... Go to PubMed...
  19. Kellner CH, Tobias KG, Jakubowski LM, et al. Electroconvulsive Therapy for an Urgent Social Indication. J ECT 2009 (in print). Go to original source... Go to PubMed...
  20. Chanpattana W, Kramer BA, Kunigiri G, et al. A Survey of the Practice of Electroconvulsive Therapy in Asia. J ECT 2009 (in print). Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.